TNFRSF12A and central nervous system cancer: TNFRSF12A expression is usually low in normal tissues but significantly increases after tissue injury and in many solid tumor types (65), including glioma, breast cancer, esophageal adenocarcinoma, pancreatic cancer, and hepatocellular carcinoma.